-
-
-
-
-
-
News
-
-
Contact UsThe company focuses on the research, development, production, and sales of chemical raw materials and their formulations. All products have passed national GMP certification, and core products have successively passed official pharmaceutical regulatory certifications from multiple countries, including the EU EDQM, US FDA, Japanese PMDA, and South Korean MFDS. Following its successful listing on the Shenzhen Stock Exchange's ChiNext board on April 4, 2023, Keyuan Pharmaceutical has entered a phase of rapid development driven by both digital intelligence and capital, with its business spanning dozens of countries and regions worldwide.
R&D base
28
2025-02
28
2025-02
28
2025-02
28
2025-02
28
2025-02
28
2025-02
28
2025-02
18
2025-02
On February 14, the Shanghe Economic Development Zone held its 2024 Annual Economic Work Conference to review regional development achievements and outline key priorities for the upcoming phase. During the meeting, outstanding enterprises and individuals who excelled in 2024 were recognized and honored. Among them, Shandong Keyuan Pharmaceutical Co., Ltd. (hereafter referred to as "Keyuan Pharmaceutical"), celebrated for its exceptional industry contributions and innovative strength, was awarded both the "Outstanding Contribution Award" and the "Science & Technology Talent Award." Additionally, Jiang Hongsheng, Chairman of Keyuan Pharmaceutical, was officially appointed as the development zone's "Investment Promotion Ambassador," highlighting the company's exemplary role as a model for collaborative government-enterprise growth.
2025-02-18
11
2025-02
Celebrate the Lantern Festival with joy and embrace the warmth of togetherness. On February 12, coinciding with the vibrant Lantern Festival, Keyuan Pharmaceutical (stock code: 301281.SZ) grandly hosted a lantern riddle-solving event, enriching employees' cultural lives while strengthening team cohesion and boosting overall happiness. This event beautifully showcased Keyuan Pharmaceutical's profound and distinctive corporate culture, as well as the energetic and optimistic spirit of its dedicated workforce.
2025-02-11
05
2025-02
To further enhance the company’s core competitiveness and fully meet and adapt to market demands, Keyuan Pharmaceutical successfully organized a special meeting on new product introduction and another on improving and upgrading existing products on February 4. The meetings centered around the "One Core, Two Wings, Three Pillars" development strategy, delving into discussions on new product planning and strategies for enhancing current offerings, thereby driving the company toward transformation, upgrading, and high-quality growth.
2025-02-05
Address: No. 26, Keyuan Street, Shanghe County, Jinan City, Shandong Province
Free Service Hotline